On September 22, 2026 Cartography Biosciences, Inc., a clinical-stage biotechnology company advancing a differentiated pipeline of antibody-based cancer therapies, reported that CEO and co-founder Kevin Parker, Ph.D., will participate in the following upcoming investor conferences:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
BofA Healthcare Trailblazers Private Company Conference: September 23-24 in Boston
Needham Private Biotech and MedTech Company Virtual 1×1 Forum: October 13-14
Goldman Sachs Healthcare Private Company Conference: October 19 in New York City
Leerink Partners Biopharma Private Company Connect: October 20-21
UBS Global Biopharma Conference: November 16-17 in London
(Press release, Cartography Biosciences, SEP 22, 2026, View Source [SID1234671011])